EPITOMEE Trademark

Trademark Overview


On Monday, January 4, 2021, a trademark application was filed for EPITOMEE with the United States Patent and Trademark Office. The USPTO has given the EPITOMEE trademark a serial number of 79306250. The federal status of this trademark filing is REGISTERED as of Tuesday, April 12, 2022. This trademark is owned by EPITOMEE MEDICAL LTD. The EPITOMEE trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Nutritional supplements, vitamins, pharmaceutical preparations for the prevention and treatment of cardio-vascular diseases, metabolic diseases, neurological diseases, psychiatric diseases, hematological diseases, immune related diseases, oncological diseases, inflammatory diseases, and endocrine related diseases; all being administered via a medical device being a shapeshifting capsule

A medical device being a shapeshifting capsule which is intended to be swallowed, expanded in the stomach and excreted, for the purpose of inducing weight-loss and managing diabetes; a medical device being a shapeshifting capsule which is intended to be swallowed, expanded in the stomach and excreted, for the purpose of regulating the absorption of pharmaceuticals preparations, nutritional supplements and vitamins
epitomee

General Information


Serial Number79306250
Word MarkEPITOMEE
Filing DateMonday, January 4, 2021
Status700 - REGISTERED
Status DateTuesday, April 12, 2022
Registration Number6696099
Registration DateTuesday, April 12, 2022
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 25, 2022

Trademark Statements


Description of MarkThe mark consists of the stylized wording "EPITOMEE" with a design of a triangle inside of the "O".
Goods and ServicesNutritional supplements, vitamins, pharmaceutical preparations for the prevention and treatment of cardio-vascular diseases, metabolic diseases, neurological diseases, psychiatric diseases, hematological diseases, immune related diseases, oncological diseases, inflammatory diseases, and endocrine related diseases; all being administered via a medical device being a shapeshifting capsule
Goods and ServicesA medical device being a shapeshifting capsule which is intended to be swallowed, expanded in the stomach and excreted, for the purpose of inducing weight-loss and managing diabetes; a medical device being a shapeshifting capsule which is intended to be swallowed, expanded in the stomach and excreted, for the purpose of regulating the absorption of pharmaceuticals preparations, nutritional supplements and vitamins

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 15, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, March 15, 2021
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEPITOMEE MEDICAL LTD
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressIL

Party NameEPITOMEE MEDICAL LTD
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressIL

Party NameEPITOMEE MEDICAL LTD
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressIL

Trademark Events


Event DateEvent Description
Friday, October 13, 2023CHANGE OF NAME/ADDRESS REC'D FROM IB
Tuesday, September 20, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, August 26, 2022FINAL DISPOSITION NOTICE SENT TO IB
Friday, August 26, 2022FINAL DISPOSITION PROCESSED
Tuesday, July 12, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, April 12, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, January 25, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 25, 2022PUBLISHED FOR OPPOSITION
Saturday, January 22, 2022NOTIFICATION PROCESSED BY IB
Wednesday, January 5, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, January 5, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, January 5, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, December 16, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 7, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 7, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 7, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, August 22, 2021REFUSAL PROCESSED BY IB
Thursday, August 5, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, August 5, 2021REFUSAL PROCESSED BY MPU
Saturday, July 24, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, July 23, 2021NON-FINAL ACTION WRITTEN
Tuesday, July 13, 2021ASSIGNED TO EXAMINER
Friday, March 19, 2021APPLICATION FILING RECEIPT MAILED
Monday, March 15, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 11, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB